NYSE:EBS Emergent Biosolutions Q3 2026 Earnings Date & Estimates $6.36 -0.02 (-0.24%) Closing price 10/19/2026 03:59 PM EasternExtended Trading$6.40 +0.04 (+0.55%) As of 10/19/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Emergent Biosolutions is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 2, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Emergent Biosolutions in Q3 2026Emergent Biosolutions is expected to post earnings of -$0.37 per share on revenue of $123.22 million. In the same quarter a year earlier Emergent Biosolutions reported $1.06 per share on revenue of $231.10 million. Emergent Biosolutions last reported on August 5, 2026, posting $0.60 per share and beating the -$0.0850 consensus estimate. Emergent Biosolutions has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.37Expected Revenue$123.22 millionPrior-Year EPS$1.06Prior-Year Revenue$231.10 millionExpected EPS Growth-134.9%Expected Revenue Growth-46.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.60 (Beat by +$0.6850)Last Quarter Revenue$234.30 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Emergent Biosolutions Q3 2026 Earnings FAQ When does Emergent Biosolutions report Q3 2026 earnings? Emergent Biosolutions (NYSE:EBS) is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Emergent Biosolutions' Q3 2026 earnings call? Emergent Biosolutions' Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Emergent Biosolutions? Analysts expect Emergent Biosolutions to post earnings of -$0.37 per share for Q3 2026. How much revenue is Emergent Biosolutions expected to report? The consensus revenue estimate for Emergent Biosolutions is $123.22 million for Q3 2026. Emergent Biosolutions Earnings HeadlinesEmergent BioSolutions CFO Richard Lindahl to Retire at Year-EndOctober 16, 2026 | finance.yahoo.comEmergent BioSolutions stock falls as CFO plans retirementOctober 16, 2026 | uk.finance.yahoo.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)Emergent BioSolutions Announces CFO Transition Amid TransformationOctober 16, 2026 | tipranks.comEmergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. LindahlOctober 16, 2026 | businesswire.comEmergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026October 15, 2026 | finance.yahoo.comSee More Emergent Biosolutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Emergent Biosolutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Emergent Biosolutions and other key companies, straight to your email. Email Address About Emergent BiosolutionsEmergent Biosolutions (NYSE:EBS) (NYSE:EBS) is a life sciences company focused on developing, manufacturing and supplying medical countermeasures for public health threats, including chemical, biological, radiological and nuclear hazards, as well as infectious diseases. The company serves government agencies, healthcare providers and commercial customers. Emergent’s portfolio has included vaccines, therapeutics and other products used to prevent or treat serious health threats. Its offerings include BioThrax, an anthrax vaccine, and ACAM2000, a smallpox vaccine, along with products such as botulism antitoxin and vaccinia immune globulin. The company has also provided contract development and manufacturing services for pharmaceutical and biotechnology organizations. Founded in 1998, Emergent is headquartered in Gaithersburg, Maryland. Its operations and customer relationships have included the United States and international markets, with a significant portion of its business tied to government preparedness programs. Joseph C. Papa serves as the company’s chief executive officer.View Emergent Biosolutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Tesla's Roadster Reveal Hints at 2 Much Bigger MovesThe AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance AnywayRate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are DivergingMarketBeat Week in Review – 10/12 - 10/16Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?Meta Claims Frontier-Class AI Status With New Muse Wonder Models Upcoming Earnings Meta Platforms (10/21/2026)AT&T (10/21/2026)Tesla (10/21/2026)Philip Morris International (10/21/2026)Kinder Morgan (10/21/2026)CME Group (10/21/2026)Moody's (10/21/2026)Abbott Laboratories (10/21/2026)Danaher (10/21/2026)Elevance Health (10/21/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
